VIVO Cannabis: Top 10 Undervalued Drug Manufacturers Industry Stocks (VIVO)

VIVO Cannabis is now ranked among the top 10 undervalued stocks in the Drug Manufacturers industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below).

Drug Manufacturers: Major, global pharmaceutical manufacturers offering a broad and diverse line of drug and healthcare products; industry leaders that have made a significant commitment to the research and development of a long pipeline of drugs. Stocks in this category are held primarily for capital appreciation.

More about VIVO Cannabis

All data provided as-at market close February 16, 2023. The list is sorted by stocks with the greatest percentage difference between valuation and price. VIVO Cannabis ABcann Global Corp is engaged in the manufacturing and distribution of medical cannabis under a license issued by Health Canada to the Company’s wholly owned subsidiary, ABcann Medicinals Inc. VIVO Cannabis is listed under VIVO on the Toronto Stock Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs. StockCalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. StockCalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including: Discounted Cash Flow (DCF), Price & Other Comparables, Multiples, Adjusted Book Value (ABV) and Analyst Consensus

Artificial intelligence at Report on Business

Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

Author: CSN